Yet metabolite effects are compartment- and dose-dependent: acetate can fuel tumor-intrinsic c-Myc–dependent PD-L1 upregulation and immune evasion in other solid tumors, underscoring the need for cell-selective or receptor-selective delivery [82]. This evidence concerns the gene MYC and neoplasm.